Optimizing clinical phenotyping to better delineate the complex relationship between type 2 diabetes and Alzheimer’s disease

Type 2 diabetes – unmet need, unresolved pathogenesis, mTORC1-centric paradigm

(2020) Jacob Bar-Tana   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Cognitive Dysfunctions in Type 1 Diabetes

(2019) Anna Shalimova et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia

(2019) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Emerging roles for high‐density lipoproteins in neurodegenerative disorders

(2019) Afsane Bahrami et al.   BIOFACTORS

The Mediterranean, Dietary Approaches to Stop Hypertension (DASH), and Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diets Are Associated with Less Cognitive Decline and a Lower Risk of Alzheimer's Disease—A Review

(2019) Annelien C van den Brink et al.   Advances in Nutrition

Dietary Neuroketotherapeutics for Alzheimer’s Disease: An Evidence Update and the Potential Role for Diet Quality

(2019) Matthew K. Taylor et al.   Nutrients

The effects of insulin and insulin-like growth factor I on amyloid precursor protein phosphorylation in in vitro and in vivo models of Alzheimer's disease

(2019) Bhumsoo Kim et al.   NEUROBIOLOGY OF DISEASE

Diabetes, cardiovascular disease and the microcirculation

(2018) W. David Strain et al.   Cardiovascular Diabetology

Amyloid-β and Tau Pathology of Alzheimer's Disease Induced by Diabetes in a Rabbit Animal Model

(2018) Claudine L. Bitel et al.   JOURNAL OF ALZHEIMERS DISEASE

Obesity as a risk factor for Alzheimer's disease: weighing the evidence

(2017) S. Alford et al.   Obesity Reviews

Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease

(2017) Cynthia M. Carlsson   JOURNAL OF ALZHEIMERS DISEASE

Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease

(2016) Therese S Salameh et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Age, APOE and sex: Triad of risk of Alzheimer’s disease

(2016) Brandalyn C. Riedel et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective

(2015) Matthew Baumgart et al.   Alzheimers & Dementia

Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease

(2014) F. G. De Felice et al.   DIABETES

Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease

(2014) Enrique Blázquez et al.   Frontiers in Endocrinology

Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review

(2013) Ann Colosia et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

The projected effect of risk factor reduction on Alzheimer's disease prevalence

(2011) Deborah E Barnes et al.   LANCET NEUROLOGY

Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease

(2009) Robert D. Bell et al.   ACTA NEUROPATHOLOGICA

Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies

(2008) Kyriaki Gerozissis   EUROPEAN JOURNAL OF PHARMACOLOGY